A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00134927|
Recruitment Status : Completed
First Posted : August 25, 2005
Last Update Posted : January 10, 2017
|Condition or disease|
|Nicotine Dependence Tobacco Use Disorder|
The nicotine patch is an effective aid for smoking cessation. Since 1996, the nicotine patch has been re-classified from prescription to over-the-counter (OTC) status in the United States. Unlike prescription medications, post-marketing surveillance does not exist for OTC medications. The purpose of this study is to describe the characteristics of consumers who purchase OTC nicotine patches from community pharmacies and to determine the factors associated with appropriate use of nicotine patches.
This prospective, cross-sectional, observational study will include a survey of 600 consumers who purchase OTC nicotine patches at a random sample of 30 community retail pharmacies. Consumers will be recruited by an ad located in the pharmacy next to the nicotine patch product. Participants will fill out a self-administered, anonymous questionnaire at the time of OTC nicotine patch purchase at the pharmacy counter. The questionnaire will gather information about demographics, medical history, smoking history, attitudes toward the nicotine patch, and motivation to quit smoking. No study visits will be required for this study.
|Study Type :||Observational|
|Actual Enrollment :||600 participants|
|Official Title:||Usage Patterns of OTC Nicotine Patches: Consumer Survey|
|Study Start Date :||September 2005|
|Actual Primary Completion Date :||May 2006|
|Actual Study Completion Date :||November 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00134927
|United States, California|
|Department of Family and Preventive Medicine|
|La Jolla, California, United States, 92093|
|Principal Investigator:||Chih-Wen Shi, M.D., M.S.||University of California, San Diego|